151 related articles for article (PubMed ID: 20846378)
21. Serum
Wang N; Zeng L; Li Z; Zhen Y; Chen H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
[TBL] [Abstract][Full Text] [Related]
22. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
Luo X; Stock C; Burwinkel B; Brenner H
PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.
Moshayoff V; Faktor O; Laghi L; Celesti G; Peretz T; Keret D; Cohen D; Israeli E
PLoS One; 2016; 11(7):e0159522. PubMed ID: 27441409
[TBL] [Abstract][Full Text] [Related]
24. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.
Xu L; Li M; Wang M; Yan D; Feng G; An G
BMC Cancer; 2014 Sep; 14():714. PubMed ID: 25255814
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers.
Ivancic MM; Megna BW; Sverchkov Y; Craven M; Reichelderfer M; Pickhardt PJ; Sussman MR; Kennedy GD
J Surg Res; 2020 Feb; 246():160-169. PubMed ID: 31586890
[TBL] [Abstract][Full Text] [Related]
26. Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients.
Findeisen P; Röckel M; Nees M; Röder C; Kienle P; Von Knebel Doeberitz M; Kalthoff H; Neumaier M
Int J Oncol; 2008 Nov; 33(5):1001-10. PubMed ID: 18949363
[TBL] [Abstract][Full Text] [Related]
27. Blood-based biomarkers of aggressive prostate cancer.
Liong ML; Lim CR; Yang H; Chao S; Bong CW; Leong WS; Das PK; Loh CS; Lau BE; Yu CG; Ooi EJ; Nam RK; Allen PD; Steele GS; Wassmann K; Richie JP; Liew CC
PLoS One; 2012; 7(9):e45802. PubMed ID: 23071848
[TBL] [Abstract][Full Text] [Related]
28. Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B.
Omar H; Lim CR; Chao S; Lee MM; Bong CW; Ooi EJ; Yu CG; Tan SS; Abu Hassan MR; Menon J; Muthukaruppan R; Singh M; Nik Abdullah NA; Ooi BP; Ding RP; Low EJ; Tan F; Novak D; Harris DF; Yang H; Merican I; Liew CC
J Clin Gastroenterol; 2015 Feb; 49(2):150-7. PubMed ID: 25569223
[TBL] [Abstract][Full Text] [Related]
29. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.
Toiyama Y; Takahashi M; Hur K; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
J Natl Cancer Inst; 2013 Jun; 105(12):849-59. PubMed ID: 23704278
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J
Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842
[TBL] [Abstract][Full Text] [Related]
31. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
32. Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients.
Yang IP; Tsai HL; Miao ZF; Huang CW; Kuo CH; Wu JY; Wang WM; Juo SH; Wang JY
J Transl Med; 2016 Apr; 14(1):108. PubMed ID: 27126129
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of a blood-based 18-gene expression signature in colorectal cancer.
Xu Y; Xu Q; Yang L; Ye X; Liu F; Wu F; Ni S; Tan C; Cai G; Meng X; Cai S; Du X
Clin Cancer Res; 2013 Jun; 19(11):3039-49. PubMed ID: 23536436
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
[TBL] [Abstract][Full Text] [Related]
35. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
[TBL] [Abstract][Full Text] [Related]
36. Blood-based protein biomarker panel for the detection of colorectal cancer.
Fung KY; Tabor B; Buckley MJ; Priebe IK; Purins L; Pompeia C; Brierley GV; Lockett T; Gibbs P; Tie J; McMurrick P; Moore J; Ruszkiewicz A; Nice E; Adams TE; Burgess A; Cosgrove LJ
PLoS One; 2015; 10(3):e0120425. PubMed ID: 25793510
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer.
Young GP; Symonds EL; Nielsen HJ; Ferm L; Christensen IJ; Dekker E; van der Vlugt M; Mallant-Hent RC; Boulter N; Yu B; Chan M; Tevz G; LaPointe LC; Pedersen SK
Clin Epigenetics; 2021 Jan; 13(1):14. PubMed ID: 33478584
[TBL] [Abstract][Full Text] [Related]
38. Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study.
Wei SC; Tsao PN; Wang YT; Lin BR; Wu DC; Tsai WS; Chen JS; Wong JM
Cancer Med; 2019 Jul; 8(7):3583-3591. PubMed ID: 31063258
[TBL] [Abstract][Full Text] [Related]
39. Hsa_circ_0002320: a novel clinical biomarker for colorectal cancer prognosis.
Yang N; Xu B; Kong P; Han M; Li BH
Medicine (Baltimore); 2020 Jul; 99(28):e21224. PubMed ID: 32664176
[TBL] [Abstract][Full Text] [Related]
40. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
